- Home
- CUE vs VGI Comparison
CUE vs VGI Comparison
Compare CUE & VGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUE
- VGI
- Stock Information
- Founded
- CUE 2014
- VGI 2012
- Country
- CUE United States
- VGI United States
- Employees
- CUE N/A
- VGI N/A
- Industry
- CUE Biotechnology: Pharmaceutical Preparations
- VGI Investment Managers
- Sector
- CUE Health Care
- VGI Finance
- Exchange
- CUE Nasdaq
- VGI Nasdaq
- Market Cap
- CUE 94.4M
- VGI 89.5M
- IPO Year
- CUE 2018
- VGI N/A
- Fundamental
- Price
- CUE $1.32
- VGI $7.82
- Analyst Decision
- CUE Strong Buy
- VGI
- Analyst Count
- CUE 5
- VGI 0
- Target Price
- CUE $5.00
- VGI N/A
- AVG Volume (30 Days)
- CUE 195.8K
- VGI 46.0K
- Earning Date
- CUE 03-10-2025
- VGI 01-01-0001
- Dividend Yield
- CUE N/A
- VGI 12.66%
- EPS Growth
- CUE N/A
- VGI N/A
- EPS
- CUE N/A
- VGI N/A
- Revenue
- CUE $9,532,000.00
- VGI N/A
- Revenue This Year
- CUE $73.11
- VGI N/A
- Revenue Next Year
- CUE $11.02
- VGI N/A
- P/E Ratio
- CUE N/A
- VGI N/A
- Revenue Growth
- CUE 149.53
- VGI N/A
- 52 Week Low
- CUE $0.45
- VGI $6.68
- 52 Week High
- CUE $2.37
- VGI $7.99
- Technical
- Relative Strength Index (RSI)
- CUE 48.32
- VGI 53.39
- Support Level
- CUE $1.22
- VGI $7.70
- Resistance Level
- CUE $1.54
- VGI $7.87
- Average True Range (ATR)
- CUE 0.11
- VGI 0.06
- MACD
- CUE -0.01
- VGI -0.00
- Stochastic Oscillator
- CUE 35.29
- VGI 48.00
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.
About VGI Virtus Global Multi-Sector Income Fund of Beneficial Interest
Virtus Global Multi-Sector Inc is a United States-based diversified, closed-end management investment company. Its investment objective is to maximize current income while preserving capital. The Fund seeks to achieve its investment objectives by capitalizing on opportunities across undervalued areas of the global bond markets.